Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Stents for proximal esophageal cancer: A case-control study
Gastrointestinal Endoscopy, Volume 73, No. 6, Year 2011
Notification
URL copied to clipboard!
Description
Background: Self-expandable metal stents (SEMSs) are an established palliative therapy for esophageal cancer. SEMS placement for cancers near the upper esophageal sphincter (UES) is controversial because of a perceived increased risk of complications. Objective: To compare outcomes after patients stented for proximal esophageal cancer (PC) and distal esophageal cancer (DC). Design: Matched case-control study from a prospective database. Setting: Tertiary referral center, Tenwek Hospital, Bomet, Kenya. Patients: All patients with PC located within 6 cm of the UES were matched with randomly selected controls with DC. Interventions: Outcomes of PC cases were compared with those of DC controls. Main Outcome Measurements: Dysphagia score, complications, median survival. Results: A total of 151 patients with PC were identified and were randomly matched with DC controls. Ninety-three case-control pairs had adequate follow-up information available. Mean dysphagia scores (scale 0-4) improved from 3.4 and 3.3 before stenting for PC and DC, respectively, to 1.5 after stenting for both groups (P = .93). Early complications occurred in 6.5% of PC cases and 9.7% of DC controls (P = .44). Late complications occurred in 20.4% of PC cases and 15.1% of DC controls (P = .25). Median survival was 210 days for PC cases and 272 days for DC controls (P = .25). Outcomes were similar for the subgroup of PC cases whose cancer extended to within 2 cm of the UES. Limitation: An important limitation is the absence of adequate follow-up data for 58 of the 151 case-control pairs. Conclusions: SEMSs effectively palliate dysphagia in PC cases, whereas complication and survival rates are not statistically different from those of DC controls. Copyright © 2011 by the American Society for Gastrointestinal Endoscopy.
Authors & Co-Authors
Parker, Robert K.
Kenya, Bomet
Tenwek Hospital
United States, Providence
The Warren Alpert Medical School
White, Russell E.
Kenya, Bomet
Tenwek Hospital
United States, Providence
The Warren Alpert Medical School
Topazian, Mark D.
United States, Rochester
Mayo Clinic
Chepkwony, Robert
Kenya, Bomet
Tenwek Hospital
Dawsey, Sonja P.
Kenya, Bomet
Tenwek Hospital
Enders, Felicity T.
United States, Rochester
Mayo Clinic
Statistics
Citations: 25
Authors: 6
Affiliations: 3
Identifiers
Doi:
10.1016/j.gie.2010.11.036
ISSN:
00165107
e-ISSN:
10976779
Research Areas
Cancer
Health System And Policy
Study Design
Cohort Study
Case-Control Study
Study Locations
Kenya